Publications by authors named "Adva Avisar"

Claim this Profile
P
Positive affect and fatigue as predictors of anti-inflammatory IL-10 concentrations among colorectal cancer patients during adjuvant chemotherapy.
Adva Avisar, Miri Cohen, Anat Aharon, Rina Katz, Gil Bar-Sela

J Psychosom Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating blood extracellular vesicles as a tool to assess endothelial injury and chemotherapy toxicity in adjuvant cancer patients.
Gil Bar-Sela, Idan Cohen, Adva Avisar, David Loven, Anat Aharon

PLoS One· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular Vesicles Reflect the Efficacy of Wheatgrass Juice Supplement in Colon Cancer Patients During Adjuvant Chemotherapy.
Adva Avisar, Miri Cohen, Benjamin Brenner, Tomer Bronshtein, Marcelle Machluf

Front Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wheatgrass Juice Administration and Immune Measures during Adjuvant Chemotherapy in Colon Cancer Patients: Preliminary Results.
Adva Avisar, Miri Cohen, Rina Katz, Talia Shentzer Kutiel, Anat Aharon

Pharmaceuticals (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the clinical use of cannabis by oncology patients advisable?
Gil Bar-Sela, Adva Avisar, Ron Batash, Moshe Schaffer

Curr Med Chem· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature.
Adva Avisar, Yaron River, Elad Schiff, Gil Bar-Sela, Mariana Steiner

Breast Cancer Res Treat· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis